This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Donna Dambach: Innovator in Hepatotoxicity Biomarkers
Introduction
Donna Dambach is a prominent inventor based in Wyncote, PA (US). She has made significant contributions to the field of biomedical research, particularly in the identification of biomarkers for liver toxicity. Her work is crucial for predicting the hepatotoxic effects of various drugs and therapeutic agents.
Latest Patents
Donna Dambach holds 1 patent related to her innovative research. The patent, titled "Identification of biomarkers for liver toxicity," focuses on biomarker polypeptides, polynucleotides, and antibodies that can predict in vitro and/or in vivo hepatotoxicity. This invention includes screens, kits, microarrays, and cell culture systems that utilize these biomolecules. The methods and reagents developed through her research are instrumental in identifying substances that may cause liver injury, thereby preventing serious medical complications such as liver failure.
Career Highlights
Throughout her career, Donna has been associated with Bristol-Myers Squibb Company, where she has applied her expertise in biomarker research. Her work has been pivotal in advancing the understanding of drug-induced liver toxicity, which is a critical area in pharmaceutical development.
Collaborations
Donna has collaborated with notable colleagues, including Stephen K. Durham and Stanley Hefta. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Donna Dambach's contributions to the field of hepatotoxicity biomarkers exemplify her dedication to improving drug safety and efficacy. Her innovative work continues to have a lasting impact on biomedical research and pharmaceutical development.